FibroBiologics (FBLG) Institutional Ownership $0.64 +0.03 (+4.72%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$0.64 0.00 (0.00%) As of 07/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for FibroBiologics (NASDAQ:FBLG)Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$10.68MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$236.53K Get FBLG Insider Trade Alerts Want to know when executives and insiders are buying or selling FibroBiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FBLG Institutional Buying and Selling by Quarter FibroBiologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025AQR Capital Management LLC32,227$29K0.0%N/A0.084% 5/13/2025Cascade Financial Partners LLC260,081$234K0.0%-8.0%0.680% 5/12/2025Nuveen LLC34,540$31K0.0%N/A0.090% 4/30/2025Cerity Partners LLC93,407$84K0.0%+19.6%0.248% 2/14/2025Jane Street Group LLC61,074$122K0.0%+415.3%0.168% 2/13/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.051% 2/13/2025Cerity Partners LLC78,101$156K0.0%+49.9%0.215% 2/12/2025O Shaughnessy Asset Management LLC40,404$81K0.0%N/A0.111% 2/11/2025Virtu Financial LLC14,862$30K0.0%N/A0.041% 2/11/2025Intech Investment Management LLC12,653$25K0.0%N/A0.035% Get the Latest News and Ratings for FBLG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FibroBiologics and its competitors with MarketBeat's FREE daily newsletter. 2/7/2025Cascade Financial Partners LLC282,601$565K0.1%-6.6%0.803% 2/6/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.053% 11/19/2024Barclays PLC39,958$123K0.0%+363.2%0.115% 11/16/2024Geode Capital Management LLC599,760$1.85M0.0%+90.0%1.706% 11/15/2024Barclays PLC39,958$123K0.0%+363.2%0.114% 11/15/2024Jane Street Group LLC11,852$37K0.0%N/A0.034% 11/15/2024State Street Corp475,837$1.47M0.0%+26.5%1.353% 11/13/2024The Manufacturers Life Insurance Company10,264$32K0.0%N/A0.029% 11/12/2024Charles Schwab Investment Management Inc.69,732$215K0.0%+5.2%0.198% 10/22/2024Symphony Financial Ltd. Co.23,772$76K0.0%N/A0.067% 8/14/2024Marshall Wace LLP16,702$83K0.0%-67.9%0.047% 8/12/2024Mercer Global Advisors Inc. ADV10,272$51K0.0%N/A0.029% 8/6/2024Fund Evaluation Group LLC1,055,105$5.27M0.3%N/A3.001% 8/6/2024Cahaba Wealth Management Inc.14,702$73K0.0%N/A0.041% 8/1/2024Rhumbline Advisers23,057$115K0.0%N/A0.065% 7/31/2024Cascade Financial Partners LLC315,055$1.57M0.2%N/A0.882% 7/31/2024Concurrent Investment Advisors LLC35,283$176K0.0%N/A0.099% 7/26/2024Bank of New York Mellon Corp68,558$342K0.0%N/A0.192% 7/23/2024RMR Wealth Builders37,360$186K0.0%N/A0.105% 7/18/2024Saxon Interests Inc.21,214$106K0.1%N/A0.059% 7/17/2024ERn Financial LLC31,819$159K0.0%N/A0.089% 7/15/2024Transform Wealth LLC133,890$668K0.1%N/A0.375% (Data available from 1/1/2016 forward) FBLG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FBLG shares? During the previous two years, 26 institutional investors and hedge funds held shares of FibroBiologics. The most heavily invested institutionals were Fund Evaluation Group LLC ($5.27M), Geode Capital Management LLC ($1.85M), State Street Corp ($1.47M), Transform Wealth LLC ($668K), Bank of New York Mellon Corp ($342K), Cascade Financial Partners LLC ($234K), and Charles Schwab Investment Management Inc. ($215K).Learn more on FibroBiologics' institutional investors. Which institutional investors have been buying FibroBiologics' stock? Of the 25 institutional investors that purchased FibroBiologics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fund Evaluation Group LLC ($1.06M), Cascade Financial Partners LLC ($315.06K), Geode Capital Management LLC ($284.05K), Transform Wealth LLC ($133.89K), State Street Corp ($99.79K), Bank of New York Mellon Corp ($68.56K), and Barclays PLC ($62.66K). How much institutional buying is happening at FibroBiologics? Institutional investors have bought a total of 2,504,651 shares in the last 24 months. This purchase volume represents approximately $10.68M in transactions. Which of FibroBiologics' major shareholders have been selling company stock? The following institutional investors have sold FibroBiologics stock in the last 24 months: Cascade Financial Partners LLC ($42.52K), and Marshall Wace LLP ($35.32K). How much institutional selling is happening at FibroBiologics? Institutional investors have sold a total of 77,843 shares in the last 24 months. This volume of shares sold represents approximately $236.53K in transactions. Related Companies OCX Institutional Ownership CRBP Institutional Ownership ADAG Institutional Ownership ENTX Institutional Ownership ORMP Institutional Ownership IVVD Institutional Ownership ELUT Institutional Ownership CHRS Institutional Ownership UNCY Institutional Ownership XBIT Institutional Ownership This page (NASDAQ:FBLG) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.